IM Cannabis (IMCC) Income towards Parent Company (2020 - 2026)

IM Cannabis' (IMCC) quarterly Income towards Parent Company came in at -$1.8 million in Q1 2026, down 1575.03% year-on-year from $121960.4 in Q1 2025, and up 67.14% quarter-over-quarter from -$5.5 million in Q4 2025.

IM Cannabis (IMCC) Income towards Parent Company (2020 - 2026) Analysis & Trends

IM Cannabis' Income towards Parent Company history runs 7 years deep, the most recent figure standing at -$1.8 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company fell 1575.03% year-over-year to -$1.8 million in Q1 2026; TTM through Mar 2026 was -$5.8 million, a 69.75% increase from a year earlier, with the FY2025 full-year figure at -$8.1 million, down 4.99% from the prior year.
  • Income towards Parent Company advanced to -$1.8 million in Q1 2026 per IMCC's latest filing, from -$5.5 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $2.9 million in Q1 2022 and bottomed at -$94.8 million in Q3 2022.
  • The 5-year median for Income towards Parent Company is -$1.2 million (2025), against an average of -$8.8 million.
  • Across the five-year window, Income towards Parent Company tumbled 2124020250.79% in 2024 and jumped 492.52% in 2025, its largest moves.
  • Year by year, Income towards Parent Company stood at -$17.5 million in 2022, then advanced by 29.04% to -$12.4 million in 2023, then declined by 16.0% to -$14.4 million in 2024, then surged by 62.07% to -$5.5 million in 2025, then soared by 67.14% to -$1.8 million in 2026.
  • Per Business Quant, the three latest IMCC Income towards Parent Company figures stand at -$1.8 million (Q1 2026), -$5.5 million (Q4 2025), and $2.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 IM Cannabis 517,043.18 -215,079.33 1.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.80 Mn
Dec 31, 2025 -5.47 Mn
Sep 30, 2025 2.65 Mn
Jun 30, 2025 -1.16 Mn
Mar 31, 2025 121,960.38
Dec 31, 2024 -14.43 Mn
Sep 30, 2024 -675,875.24
Jun 30, 2024 -4.11 Mn
Mar 31, 2024 -4.47 Mn
Dec 31, 2023 -12.44 Mn
Sep 30, 2023 1.59 Mn
Jun 30, 2023 0.19
Mar 31, 2023 -664,247.34
Dec 31, 2022 -17.53 Mn
Sep 30, 2022 -94.80 Mn
Jun 30, 2022 -2.45
Mar 31, 2022 2.89 Mn
Dec 31, 2021 -3.27 Mn
Sep 30, 2021 -5.15 Mn
Jun 30, 2021 -3.77 Mn